Skip to main contentSkip to feedback
U.S. flag

An official website of the United States government

AstraZeneca to Pay $7.9 Million to Resolve Kickback Allegations

AstraZeneca LP, a pharmaceutical manufacturer based in Delaware, has agreed to pay the government $7.9 million to settle allegations that it engaged in a kickback scheme in violation of the False Claims Act, the Justice Department announced today. AstraZeneca markets and sells pharmaceutical products in the United States, including a drug sold under the trade name Nexium.

Read more on www.justice.gov

Action Details

  • Date:February 11, 2015
  • Agency:U.S. Department of Justice
  • Enforcement Types:
    • Criminal and Civil Actions